Monoclonal antibodies against tumor-associated antigens, process

Details Monoclonal antibodies against tumor-associated antigens, process Monoclonal antibodies against tumor-associated antigens, process

1995-06-07

1997-12-09

Feisee, Lila

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Structurally-modified antibody, immunoglobulin, or fragment...

4241381, 4241741, 435328, 435330, 435344, 435355, 5303873, 5303877, 5303888, A61K 39395, C12N 512

Patent

active

056957580

ABSTRACT:
The invention relates to monoclonal antibodies against a tumor-associated antigen which is mainly derived from tumors from the group of carcinomas of the breast, ovaries and prostate, as well as adenocarcinomas of the lung, which additionally react with polymorphic epithelial mucin (PEM), to the preparation and use thereof and to the use of the epitope defined by the antibody for diagnosis and therapy.

REFERENCES:
"Monoclonal Antibodies Identify a CEA Crossreacting Antigen of 95 kD (NCA-95) Distinct in Antigenicity and Tissue Distribution From the Previously Described NCA of 55 kD", Buchegger et al., Int. J. Cancer, 33:643-649 (1984).
"Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas", Bosslet et al., Eur. J. Nucl. Med., 14:523-528 (1988).
"Isolation and Characterization of Mucin-Like Glycoprotein in Human Milk Fat Globule Membrane", Shimizu et al., J. Biochem, 91:515-524 (1982).
"A Core Protein Epitope of the Polymorphic Epithelial Mucin Detected by the Monoclonal Antibody SM-3 is Selectively Exposed in a Range of Primary Carcinomas", Girling et al., Int. J. Cancer, 43:1072-1076 (1989).
"Monoclonal Antibodies to Epithelium-Specific Components of the Human Milk Fat Gloubule Membrane: Production and Reaction With Cells in Culture", Taylor-Papadimitriou et al., Int. J. Cancer, 28:17-21 (1981).
"A Decade of Development in Immunoassay Methodology", Gosling, Clin. Chem., 36(8): 1408-1427 (1990).
"Immunoenzymatic Labeling of Monoclonal Antibodies Using Immune Complexes of Alkaline Phosphatase and Monoclonal Anti-alkaline Phosphatase (APAAP Complexes)", Cordell et al., Journal of Histochemistry and Cytochemistry, 32(2): 219-229 (1984).
"Cloning immunoglobulin variable domains for expression by the polymerase chain reaction", Orlandi et al., Proc.Natl.Acad.Sci.USA,86:3833-3837(1989).
"DNA sequencing with chain-terminating inhibitors", Sanger et al., Proc. Natl.Acad.Sci. USA, 74(12): 5463-5467 (1977).
"Monoclonal Antibody Therapeutic Trials in Seven Patients With T-Cell Lymphoma", Miller et al., Blood, 62(5): 988-995 (1983).
"In vivo labelling of granulocytes with .sup.99m Tc anti-NCA monoclonal anti-bodies for imaging inflammation", Joesph et al., Eur.J.Nucl.Med., 14:367-373 (1988).
"Replacing the complementarity-determining regions in a human antibody with those from a mouse", Jones et al., Nature, 321:522-525 (1986).
"Reshaping human antibodies for therapy", Riechmann et al., Nature, 332:323-327 (1988).
"Reshaping Human Antibodies: Grafting an Antilysozyme Activity", Verhoeyen et al., Science, 239:1534-1536 (1988).
"Sequence of Proteins of Immunological Interest", Kabat et al.,4th Edition, US Department of Health and Human Services, US Government Printing Office (1987).
"Molecular Cloning, A Laboratory Manual", Sambrook, Fritsch, Maniatis; Cold Spring Harbor Laboratory, pp. 11-44,51-127,133-134,141,146,150-167, 170, 188-193, 197-199, 248-255, 270-294, 310-328, 364-401, 438-506, (1982).
"Molecular Cloning, A Laboratory Manual", Sambrook, Fritsch, Maniatis; Second Edition, Cold Spring Harbor Press, pp. 16.20-16, 16.30-16.40, 16.54-16.55, (1989).
"Isolation of overproducing recombinant mammalian cell lines by a fast and simple selection procedure", Wirth et al., Gene 73: 419-426 (1988).
"Evolution of Human Immunoglobulin k J Region Genes*", Hieter et al., The Journal of Biological Chemistry, 257(3): 1516-1522 (1982).
"Humanization of Monoclonal Antibodies", Gussow et al., Methods in Enzymology, 203:99-121 (1991).
"Design and Synthesis of a Mimetic from an Antibody Complementarity-Determining Region", Saragovi et al., Science, 253:792-795 (1991).
"The immobilization of immunoreactants on solid phases", Tijssen, Practice & Theory of Enzyme Immunoassays, pp. 297-328, (1984).
"Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors", Kufe et al., Hybridoma, 3(3): 223-232 (1984).
Price et al Cancer Immunol Immunother. 1990 vol. 31 : 269-272.
Girling, et al.; International Journal of Cancer, vol. 43, pp. 1072-1076; 1989.
Jones, et al.; Nature, vol. 321, pp. 522-525; May 29, 1986.
Gussow, et al.. ; Methods in Enzymology, vol. 203, pp. 99-121; 1991.
Burchell, et al.; Cancer Research, vol. 47, pp. 5476-5482; Oct. 15, 1987.
Briggs et al. 1993 Euro J. Cancer vol. 29A(2): 230-237.
Paul et al 1993 Fundamental Immunology p. 242.

Affiliated with

Also associated with

Rating

Monoclonal antibodies against tumor-associated antigens, process does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibodies against tumor-associated antigens, process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies against tumor-associated antigens, process will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1605519